Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study
Guo‐Tian Ruan(Beijing Friendship Hospital), Hanping Shi(Beijing Shijitan Hospital), Yizhen Gong, Hailun Xie(Guangxi Medical University), Mengmeng Song(China Pharmaceutical University), Heyang Zhang(Academy of Military Medical Sciences), Yongbing Chen(Naval University of Engineering), Qi Zhang(The University of Texas MD Anderson Cancer Center), Xi Zhang(Shanghai Jiao Tong University), Ziwen Wang(Shanghai Children's Medical Center), Minghua Cong(Chinese Academy of Medical Sciences & Peking Union Medical College), Kunhua Wang(Yunnan University), Li Deng(Capital Medical University), Xiaowei Zhang(Shanghai Medical College of Fudan University), Kaiying Yu(Capital Medical University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Meng Tang(Capital Medical University)
Cited by 19
Related Papers
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
|Nature Medicine|2023|372
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
|Journal of Experimental & Clinical Cancer Research|2019|221
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
|Signal Transduction and Targeted Therapy|2022|177
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170